Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
She was moments away from giving birth. The hospital discharged her - 27 Methods for further developing Rest Quality
- 3Four Dead in Last Month From Animal Attacks in Nepal
- 4Kids get diseases like lupus, too. As researchers hunt better treatments, this camp brings joy
- 5The Best Internet based Retailers for Style and Frill
- EU Commission prepares €90bn Ukraine loan despite Hungary's veto
- 2025 among world's three hottest years on record, WMO says
- The gay hockey show no one saw coming — and everyone is suddenly obsessed with
- Ukraine to get up to 100 French-made Rafale fighter jets
- Activists Took BMW and Mercedes to Court Over Gas Cars. It Didn’t Stick
- IDF kills senior PIJ Gaza City Brigade cmdr. who infiltrated Kibbutz Nahal Oz on Oct. 7
- Australia’s post-Bondi crackdown accused of targeting pro-Palestinian voices
- Data centers in space: Will 2027 really be the year AI goes to orbit?
- Mickey Lee of 'Big Brother' fame dead at 35 after flu complications, family says
